321 related articles for article (PubMed ID: 2878066)
1. Imaging of medullary thyroid carcinoma and hyperfunctioning adrenal medulla using iodine-131 metaiodobenzylguanidine.
Ansari AN; Siegel ME; DeQuattro V; Gazarian LH
J Nucl Med; 1986 Dec; 27(12):1858-60. PubMed ID: 2878066
[TBL] [Abstract][Full Text] [Related]
2. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
[TBL] [Abstract][Full Text] [Related]
3. [Clinical applications of 131I-meta iodobenzylguanidine (131I-MIBG) scintigraphy in Japan].
Izumi M; Kakezono F; Nagayama Y; Kiriyama T; Yokoyama N; Yamashita S; Morita S; Hirayu H; Kubo I; Ohtakara S
Kaku Igaku; 1986 Feb; 23(2):145-52. PubMed ID: 2872353
[No Abstract] [Full Text] [Related]
4. Detection of metastatic medullary thyroid cancer with 131I-MIBG scans in Sipple's syndrome.
Itoh H; Sugie K; Toyooka S; Kawase M; Mukaino S; Hazama F; Endo K; Torizuka K; Nakao K; Imura H
Eur J Nucl Med; 1986; 11(12):502-4. PubMed ID: 2874028
[TBL] [Abstract][Full Text] [Related]
5. [The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
Sasaki Y; Kubo A; Kusakabe K; Masaki H; Endo K; Yamashita M; Nakajo M; Kaneko M
Kaku Igaku; 1992 Sep; 29(9):1083-98. PubMed ID: 1360549
[TBL] [Abstract][Full Text] [Related]
6. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
[TBL] [Abstract][Full Text] [Related]
7. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers.
Jansson S; Tisell LE; Fjälling M; Lindberg S; Jacobsson L; Zachrisson BF
Surgery; 1988 Jan; 103(1):11-8. PubMed ID: 2892276
[TBL] [Abstract][Full Text] [Related]
8. Pitfall of Sipple's syndrome diagnosis by 131I-metaiodobenzylguanidine (MIBG).
Talbot JN; Coutris G; Moulonguet M; Hoang C; Perniceni T; Milhaud G
J Nucl Med Allied Sci; 1987; 31(4):337-40. PubMed ID: 2895168
[No Abstract] [Full Text] [Related]
9. Zona fasciculata cortical adenoma and adrenal medullary hyperplasia in MEN II patient: unique concurrent presentation.
Krubsack AJ; Arnaout MA; Hagen TC; Zielonka JS; Choi HY; Akhtar R; Schulte WJ
Clin Nucl Med; 1988 Oct; 13(10):730-3. PubMed ID: 2902945
[TBL] [Abstract][Full Text] [Related]
10. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.
Nakajo M; Shapiro B; Copp J; Kalff V; Gross MD; Sisson JC; Beierwaltes WH
J Nucl Med; 1983 Aug; 24(8):672-82. PubMed ID: 6135764
[TBL] [Abstract][Full Text] [Related]
11. Methodology and dosimetry in adrenal medullary imaging with iodine-131 MIBG.
Lindberg S; Fjälling M; Jacobsson L; Jansson S; Tisell LE
J Nucl Med; 1988 Oct; 29(10):1638-43. PubMed ID: 2902204
[TBL] [Abstract][Full Text] [Related]
12. Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study.
Baulieu JL; Guilloteau D; Delisle MJ; Perdrisot R; Gardet P; Delépine N; Baulieu F; Dupont JL; Talbot JN; Coutris G
Cancer; 1987 Nov; 60(9):2189-94. PubMed ID: 2894239
[TBL] [Abstract][Full Text] [Related]
13. Limitations of 131I-MIBG scintigraphy in locating pheochromocytomas.
Gough IR; Thompson NW; Shapiro B; Sisson JC
Surgery; 1985 Jul; 98(1):115-20. PubMed ID: 2861667
[TBL] [Abstract][Full Text] [Related]
14. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.
Shapiro B; Copp JE; Sisson JC; Eyre PL; Wallis J; Beierwaltes WH
J Nucl Med; 1985 Jun; 26(6):576-85. PubMed ID: 2860214
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of iodine-123 MIBG uptake by normal adrenal medulla in hypertensive patients.
Bomanji J; Flatman WD; Horne T; Fettich J; Britton KE; Ross G; Besser GM
J Nucl Med; 1987 Mar; 28(3):319-24. PubMed ID: 3819850
[TBL] [Abstract][Full Text] [Related]
16. Adrenal medullary disease in multiple endocrine neoplasia type II.
Cho KJ; Freier DT; McCormick TL; Nishiyama RH; Forrest ME; Kaufman A; Borlaza GS
AJR Am J Roentgenol; 1980 Jan; 134(1):23-9. PubMed ID: 6766032
[TBL] [Abstract][Full Text] [Related]
17. Pheochromocytoma in multiple endocrine neoplasia type 2A: positive 123I MIBG with negative CT and equivocal 131I MIBG imaging.
Ishii S; Shishido F; Miyajima M; Sakuma K; Kikuchi K
Clin Nucl Med; 2012 Jun; 37(6):596-8. PubMed ID: 22614196
[TBL] [Abstract][Full Text] [Related]
18. [Adrenomedullary scintigraphy with I-131 metaiodobenzylguanidine].
Ohta Y; Takahashi E; Matsumoto Y; Kawasaki Y; Maki M; Hiroe D; Kusakabe K
Rinsho Hoshasen; 1985 Mar; 30(3):399-400. PubMed ID: 4021133
[No Abstract] [Full Text] [Related]
19. Multiple endocrine neoplasia type 2 with malignant pheochromocytoma--long term follow-up of a case by 131I-meta-iodobenzylguanidine scintigraphy.
Namba H; Kondo H; Yamashita S; Kimura H; Yokoyama N; Tsuruta M; Sato A; Izumi M; Kinoshita H; Hakariya S
Ann Nucl Med; 1992 May; 6(2):111-5. PubMed ID: 1352456
[TBL] [Abstract][Full Text] [Related]
20. Adrenal angiography in Sipple's syndrome.
Ekelund L; Hoevels J
Acta Radiol Diagn (Stockh); 1979; 20(4):637-47. PubMed ID: 525405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]